News

Providence Cancer Center Clinical Trials

DateNews

05/21/2013

Providence Cancer Center first in nation to offer unique trial treatment for lymphoma patients

People with B-cell non-Hodgkin's lymphoma or chronic lymphocytic leukemia have a unique opportunity to participate in groundbreaking research at Provi More>>

05/17/2013

An outpouring of giving: More than $400,000 boosts cancer research at Providence

Cancer survivors and researchers shared the stage at Providence Cancer Center’s 15th annual “Positive Perspectives: Creating Hope for Cancer Patients More>>

03/15/2013

NIH grant furthers promising metastatic melanoma clinical trials for Providence Cancer Center patients

Patients with advanced melanoma are getting a boost from work being done at Providence, thanks to a grant from the National Institutes of Health. More>>

09/28/2012

Providence Cancer Center recognized for commitment to quality and excellence

Providence is the only cancer facility in Oregon to receive QOPI certification. More>>

05/08/2012

Pennies, nickels and dimes add up to $500,000 as Safeway customers and employees help Providence battle breast cancer

Safeway customers and employees in Oregon and Southwest Washington raised $500,000 for breast cancer awareness, treatment and research at Providence. More>>

10/24/2011

Providence selected for nationwide immunotherapy network

Providence Cancer Center is among North America's top research institutions invited to join the national Cancer Immunotherapy Trials Network. More>>

04/11/2011

Providence cancer drug trial wins FDA approval

Ipilimumab is the first drug shown to extend survival in patients with late-stage melanoma. More>>